+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biochips Market - Global Forecast to 2030- Product Image
Biochips Market - Global Forecast to 2030- Product Image
New

Biochips Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082840
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biochips Market grew from USD 24.10 billion in 2024 to USD 29.05 billion in 2025. It is expected to continue growing at a CAGR of 19.59%, reaching USD 70.55 billion by 2030.

The advent of high-throughput bioanalytical platforms has transformed how researchers interrogate molecular processes, accelerating discovery in diagnostics, genomics, proteomics and drug development. Biochips-miniaturized devices integrating biological sensing elements with microfabricated components-have evolved from niche laboratory tools into foundational technologies in life sciences. By combining microfluidics, microelectronics and MEMS-based sensors, modern biochips deliver rapid, parallel analyses with unprecedented sensitivity and specificity. As complexity grows, so does the requirement for robust fabrication methods, precise reagents handling and seamless data integration.

This executive summary provides a concise yet comprehensive overview of the biochips market, exploring pivotal shifts in technology, regulatory influences such as new U.S. tariffs, critical segmentation insights, regional adoption patterns and the competitive landscape. Each section is designed to equip decision-makers with actionable intelligence-highlighting emerging trends, potential challenges and strategic opportunities. By synthesizing the latest developments across chip types, fabrication technologies, component innovation, application domains and end-user preferences, this analysis serves as a strategic guide for stakeholders seeking to navigate the rapidly changing terrain of biochip innovation. Ultimately, this summary underscores the imperative for agility, collaboration and forward-looking investment to harness the full potential of biochips in advancing precision medicine and life-science research.

Transformative Shifts Redefining Biochips Innovation

Over the past decade, several transformative shifts have redefined the biochips landscape. First, the convergence of microfluidics and microelectronics has enabled lab-on-chip platforms to perform complex assays on microliter volumes, drastically reducing sample and reagent consumption. Alongside, the integration of advanced sensors-both electrochemical and optical-has improved detection limits down to single-molecule resolution, fostering breakthroughs in early disease diagnostics.

Second, fabrication technologies have matured from purely silicon-based processes to incorporate polymers and glass, expanding design flexibility and lowering production costs. This shift has accelerated adoption of disposable microarrays and peptide microarrays for applications ranging from pathogen detection to personalized therapy monitoring.

Third, the rise of multiplexed assays has elevated the role of reagents development, prompting manufacturers to create specialized buffer and fluorescent reagents optimized for high-density arrays. Concurrently, demand from genomic and proteomic research for high-throughput screening has spurred advancements in Application Specific Integrated Microarrays, DNA Microarrays and Protein Microarrays.

Finally, digital transformation has permeated the biochips sector: cloud-based data analysis platforms, AI-driven image processing and automated workflow management are now intrinsic to competitive differentiation. These trends collectively drive a new era of precision, scalability and cost-efficiency that is shaping tomorrow’s biochips ecosystem.

Cumulative Impact of United States Tariffs in 2025

In 2025, newly imposed United States tariffs on imported microfabricated devices and associated reagents have introduced significant headwinds for global supply chains. Higher duties on silicon-based components and polymer substrates have compelled manufacturers to reevaluate sourcing strategies and absorb increased production costs. As a result, lead times for chip reader modules and flow system parts have extended, and inventory carrying costs have risen.

Ripple effects include price adjustments for end users ranging from diagnostic laboratories to contract research organizations. Some providers have begun localizing fabrication through partnerships with domestic foundries to mitigate tariff impacts, while others explore vertical integration to secure reagent supply, particularly for fluorescent reagents and substrate coatings. These adaptive measures highlight the industry’s resilience but also underscore the need for strategic agility. Going forward, tariff-driven cost pressures will continue to shape procurement, manufacturing footprints and collaborative models across the biochips value chain.

Key Segmentation Insights Driving Market Dynamics

The biochips market exhibits multifaceted segmentation that informs both product development and commercialization strategies. By type, offerings range from application specific integrated microarrays to DNA Microarrays, lab-on-chip devices, peptide microarrays and protein microarrays, each tailored to distinct assay requirements. Fabrication technology further differentiates solutions: MEMS processes deliver high-precision microstructures, microelectronics integration supports on-chip signal processing, and microfluidics platforms enable complex fluid manipulation at miniature scales.

Component segmentation reveals nuanced supply chain dependencies: chip readers and flow systems form the core hardware, while reagents-spanning buffer reagents, fluorescent reagents and substrate coatings-are critical to assay performance. Sensor technologies also vary, with electrochemical sensors optimized for label-free detection and optical sensors catering to fluorescence-based applications. Application segmentation spans diagnostics, drug discovery, endocrinology, genomics, proteomics and toxicology. In diagnostics, cancer diagnosis and pathogen detection dominate, whereas drug discovery leverages high-throughput screening and lead optimization. Genomic applications emphasize gene expression profiling and SNP genotyping, while proteomics centers on biomarker identification and protein-DNA interaction studies.

End-user insights highlight diverse customer needs: contract research and manufacturing organizations demand scalable, customizable platforms; diagnostic laboratories prioritize robustness and throughput; pharmaceutical and biotechnology firms require integration with existing R&D pipelines; academic and research institutes seek flexible, cost-effective systems. Material choice-whether glass for optical clarity, polymer for disposability or silicon for high precision-rounds out the segmentation framework, guiding design, pricing and go-to-market strategies.

Key Regional Insights Shaping Global Adoption

Regional dynamics shape biochips adoption through distinct regulatory environments, infrastructure maturity and research priorities. In the Americas, robust funding for precision medicine initiatives and established biopharma hubs have propelled demand for advanced microarrays and lab-on-chip platforms. Collaborative networks between universities, national labs and industry players accelerate translational research, particularly in cancer diagnostics and genomic profiling.

In Europe, the Middle East & Africa region, regulatory harmonization efforts and pan-regional health programs support widespread deployment of point-of-care diagnostic chips. Emphasis on antimicrobial resistance and public health surveillance drives investment in pathogen detection platforms. Local manufacturing clusters in Germany, France and Israel further enhance supply chain resilience.

Asia-Pacific stands out as a fast-growing market buoyed by government initiatives in biotechnology and life-sciences research. Countries such as China, Japan and South Korea are forging partnerships between public research institutes and major equipment manufacturers, spurring innovation in protein microarrays and peptide microarrays. Expanding contract research organization networks across India and Southeast Asia also contribute to rising demand for cost-effective, high-throughput biochip solutions.

Key Company Insights Highlighting Competitive Landscape

The competitive landscape features both established conglomerates and agile specialized firms. Abbott Laboratories has leveraged its diagnostics expertise to integrate optical sensors into multiplexed arrays, while ACROBiosystems Inc. focuses on recombinant protein quality for enhanced protein-DNA interaction studies. Agilent Technologies, Inc. continues to advance MEMS-based lab-on-chip solutions, complemented by Archer Materials Limited’s polymer microfluidics innovations. Bio-Rad Laboratories, Inc. and BioMerieux SA deliver comprehensive reagent kits and modular flow systems, and Cellix Ltd. by Randox Laboratories Ltd. has introduced novel surface coatings that improve cell-based assays.

Diagnostic Biochips, Inc. and Innovative Biochips, LLC specialize in custom microarray design, whereas F. Hoffmann-La Roche Ltd. and GE HealthCare Technologies, Inc. integrate biochip platforms into their broader diagnostic portfolios. Horiba, Ltd. and Illumina, Inc. emphasize high-throughput sequencing and microarray analytics, while LI-COR, Inc. offers near-infrared imaging systems. Luminex Corporation by DiaSorin S.p.A. excels in multiplex bead-based assays, and Merck KGaA supplies a broad range of substrate coatings and buffer reagents.

Micronit B.V. and Nutcracker Therapeutics drive microfluidics innovation, Opteev pioneers electrochemical sensing modules, and PerkinElmer Inc. provides end-to-end automation systems. Phalanx Biotech Group Inc. by WIN Semiconductors Corp. develops specialized peptide arrays, QIAGEN N.V. focuses on genomic sample preparation, Sphere Fluidics Limited innovates droplet-based platforms, Standard BioTools Inc. advances single-cell analysis, and Thermo Fisher Scientific Inc. maintains a diversified portfolio across all fabrication and application segments.

Actionable Recommendations for Industry Leaders

To thrive in this dynamic environment, industry leaders should pursue three strategic imperatives. First, invest in modular, interoperable platforms that support seamless integration of chip readers, flow systems and diverse sensor technologies. This approach will enable rapid customization for applications such as high-throughput screening, biomarker discovery and point-of-care diagnostics.

Second, cultivate strategic partnerships across the value chain-collaborating with domestic foundries to mitigate tariff impacts, co-developing specialized reagents with chemical suppliers and engaging academic consortia for early validation of novel assays. Such alliances will accelerate the translation of cutting-edge research into commercial products while optimizing cost structures.

Third, embrace digital transformation by embedding AI-driven analytics, cloud-based data management and automation into biochip workflows. Prioritizing software-enabled services and data connectivity will differentiate offerings, improve user experience and foster long-term customer loyalty. In parallel, implement robust quality management systems to ensure regulatory compliance and maintain product reliability across global markets.

Conclusion

The biochips market stands at a pivotal juncture, shaped by rapid technological advances, evolving regulations and shifting global dynamics. Stakeholders who combine deep domain expertise with strategic agility will be best positioned to capture emerging opportunities. By leveraging modular design principles, forging cross-sector partnerships and deploying digital technologies, companies can overcome supply chain pressures and accelerate innovation. As the demand for precise, high-throughput bioanalytical solutions continues to rise, those who invest in scalable, integrated platforms will lead the next wave of breakthroughs in diagnostics, drug discovery and life-science research.

Market Segmentation & Coverage

This research report categorizes the Biochips Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Application Specific Integrated Microarray
  • DNA Microarrays
  • Lab-On-Chip
  • Peptide Microarrays
  • Protein Microarrays
  • MEMS
  • Microelectronics
  • Microfluidics
  • Chip Reader
  • Flow System
  • Reagents
    • Buffer Reagents
    • Fluorescent Reagents
    • Substrate Coatings
  • Sensors
    • Electrochemical Sensors
    • Optical Sensors
  • Diagnostics
    • Cancer Diagnosis
    • Pathogen Detection
  • Drug Discovery
    • High Throughput Screening
    • Lead Optimization
  • Endocrinology
  • Genomics
    • Gene Expression Profiling
    • SNP Genotyping
  • Proteomics
    • Biomarker Identification
    • Protein-DNA Interaction Studies
  • Toxicology
  • CROs and CMOs
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Glass
  • Polymer
  • Silicon

This research report categorizes the Biochips Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biochips Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • ACROBiosystems Inc.
  • Agilent Technologies, Inc.
  • Archer Materials Limited
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Cellix Ltd. by Randox Laboratories Ltd.
  • Diagnostic Biochips, Inc
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Horiba, Ltd.
  • Illumina, Inc.
  • Innovative Biochips, LLC
  • LI-COR, Inc.
  • Luminex Corporation by DiaSorin S.p.A.
  • Merck KGaA
  • Micronit B.V.
  • Nutcracker Therapeutics
  • Opteev
  • PerkinElmer Inc.
  • Phalanx Biotech Group Inc. by WIN Semiconductors Corp.
  • QIAGEN N.V.
  • Sphere Fluidics Limited
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biochips Market, by Type
8.1. Introduction
8.2. Application Specific Integrated Microarray
8.3. DNA Microarrays
8.4. Lab-On-Chip
8.5. Peptide Microarrays
8.6. Protein Microarrays
9. Biochips Market, by Fabrication Technology
9.1. Introduction
9.2. MEMS
9.3. Microelectronics
9.4. Microfluidics
10. Biochips Market, by Component
10.1. Introduction
10.2. Chip Reader
10.3. Flow System
10.4. Reagents
10.4.1. Buffer Reagents
10.4.2. Fluorescent Reagents
10.4.3. Substrate Coatings
10.5. Sensors
10.5.1. Electrochemical Sensors
10.5.2. Optical Sensors
11. Biochips Market, by Application
11.1. Introduction
11.2. Diagnostics
11.2.1. Cancer Diagnosis
11.2.2. Pathogen Detection
11.3. Drug Discovery
11.3.1. High Throughput Screening
11.3.2. Lead Optimization
11.4. Endocrinology
11.5. Genomics
11.5.1. Gene Expression Profiling
11.5.2. SNP Genotyping
11.6. Proteomics
11.6.1. Biomarker Identification
11.6.2. Protein-DNA Interaction Studies
11.7. Toxicology
12. Biochips Market, by End User
12.1. Introduction
12.2. CROs and CMOs
12.3. Diagnostic Laboratories
12.4. Pharmaceutical and Biotechnology Companies
12.5. Research and Academic Institutes
13. Biochips Market, by Material
13.1. Introduction
13.2. Glass
13.3. Polymer
13.4. Silicon
14. Americas Biochips Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Biochips Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Biochips Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. ACROBiosystems Inc.
17.3.3. Agilent Technologies, Inc.
17.3.4. Archer Materials Limited
17.3.5. Bio-Rad Laboratories, Inc.
17.3.6. BioMerieux SA
17.3.7. Cellix Ltd. by Randox Laboratories Ltd.
17.3.8. Diagnostic Biochips, Inc
17.3.9. F. Hoffmann-La Roche Ltd.
17.3.10. GE HealthCare Technologies, Inc.
17.3.11. Horiba, Ltd.
17.3.12. Illumina, Inc.
17.3.13. Innovative Biochips, LLC
17.3.14. LI-COR, Inc.
17.3.15. Luminex Corporation by DiaSorin S.p.A.
17.3.16. Merck KGaA
17.3.17. Micronit B.V.
17.3.18. Nutcracker Therapeutics
17.3.19. Opteev
17.3.20. PerkinElmer Inc.
17.3.21. Phalanx Biotech Group Inc. by WIN Semiconductors Corp.
17.3.22. QIAGEN N.V.
17.3.23. Sphere Fluidics Limited
17.3.24. Standard BioTools Inc.
17.3.25. Thermo Fisher Scientific Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOCHIPS MARKET MULTI-CURRENCY
FIGURE 2. BIOCHIPS MARKET MULTI-LANGUAGE
FIGURE 3. BIOCHIPS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOCHIPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOCHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOCHIPS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOCHIPS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOCHIPS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOCHIPS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOCHIPS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOCHIPS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOCHIPS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOCHIPS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOCHIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION SPECIFIC INTEGRATED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOCHIPS MARKET SIZE, BY DNA MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOCHIPS MARKET SIZE, BY LAB-ON-CHIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOCHIPS MARKET SIZE, BY PEPTIDE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOCHIPS MARKET SIZE, BY MEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOCHIPS MARKET SIZE, BY MICROELECTRONICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOCHIPS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOCHIPS MARKET SIZE, BY CHIP READER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOCHIPS MARKET SIZE, BY FLOW SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOCHIPS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOCHIPS MARKET SIZE, BY BUFFER REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOCHIPS MARKET SIZE, BY FLUORESCENT REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOCHIPS MARKET SIZE, BY SUBSTRATE COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOCHIPS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOCHIPS MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOCHIPS MARKET SIZE, BY OPTICAL SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOCHIPS MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOCHIPS MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOCHIPS MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOCHIPS MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOCHIPS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOCHIPS MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOCHIPS MARKET SIZE, BY SNP GENOTYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOCHIPS MARKET SIZE, BY BIOMARKER IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEIN-DNA INTERACTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOCHIPS MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOCHIPS MARKET SIZE, BY CROS AND CMOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOCHIPS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOCHIPS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOCHIPS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOCHIPS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOCHIPS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOCHIPS MARKET SIZE, BY SILICON, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 93. CANADA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. CANADA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 96. CANADA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 97. CANADA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 98. CANADA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 100. CANADA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 101. CANADA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 102. CANADA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 103. CANADA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. CANADA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOCHIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 155. CHINA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. CHINA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. CHINA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 158. CHINA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 159. CHINA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 160. CHINA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. CHINA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. CHINA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 163. CHINA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 164. CHINA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 165. CHINA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. CHINA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 167. INDIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. INDIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. INDIA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. INDIA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 171. INDIA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 172. INDIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. INDIA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 174. INDIA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 175. INDIA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 176. INDIA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 177. INDIA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. INDIA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 191. JAPAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. JAPAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. JAPAN BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 194. JAPAN BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 195. JAPAN BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 196. JAPAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. JAPAN BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 198. JAPAN BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 199. JAPAN BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 200. JAPAN BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 201. JAPAN BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. JAPAN BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 263. THAILAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 264. THAILAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. THAILAND BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 266. THAILAND BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 267. THAILAND BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 268. THAILAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. THAILAND BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 270. THAILAND BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 271. THAILAND BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 272. THAILAND BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 273. THAILAND BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. THAILAND BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BIOCHIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 300. DENMARK BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. DENMARK BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. DENMARK BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 303. DENMARK BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 304. DENMARK BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 305. DENMARK BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. DENMARK BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 307. DENMARK BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 308. DENMARK BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 310. DENMARK BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. DENMARK BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 312. EGYPT BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 313. EGYPT BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. EGYPT BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 315. EGYPT BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 316. EGYPT BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. EGYPT BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 319. EGYPT BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 320. EGYPT BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 321. EGYPT BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 322. EGYPT BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. EGYPT BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 324. FINLAND BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 325. FINLAND BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. FINLAND BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 327. FINLAND BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 328. FINLAND BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 329. FINLAND BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. FINLAND BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 331. FINLAND BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 332. FINLAND BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 333. FINLAND BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 334. FINLAND BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. FINLAND BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 336. FRANCE BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 337. FRANCE BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 338. FRANCE BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 339. FRANCE BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 340. FRANCE BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 341. FRANCE BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. FRANCE BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 343. FRANCE BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 344. FRANCE BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 345. FRANCE BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 346. FRANCE BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. FRANCE BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 348. GERMANY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 349. GERMANY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 350. GERMANY BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 351. GERMANY BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 352. GERMANY BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 353. GERMANY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. GERMANY BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 355. GERMANY BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 356. GERMANY BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 357. GERMANY BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 358. GERMANY BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 359. GERMANY BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 360. ISRAEL BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 361. ISRAEL BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 362. ISRAEL BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 363. ISRAEL BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 364. ISRAEL BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 365. ISRAEL BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 366. ISRAEL BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 367. ISRAEL BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 368. ISRAEL BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 369. ISRAEL BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 370. ISRAEL BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 371. ISRAEL BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 372. ITALY BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 373. ITALY BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 374. ITALY BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 375. ITALY BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 376. ITALY BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 377. ITALY BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 378. ITALY BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 379. ITALY BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 380. ITALY BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 381. ITALY BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 382. ITALY BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 383. ITALY BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 384. NETHERLANDS BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 385. NETHERLANDS BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 386. NETHERLANDS BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 387. NETHERLANDS BIOCHIPS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 388. NETHERLANDS BIOCHIPS MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
TABLE 389. NETHERLANDS BIOCHIPS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 390. NETHERLANDS BIOCHIPS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 391. NETHERLANDS BIOCHIPS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 392. NETHERLANDS BIOCHIPS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 393. NETHERLANDS BIOCHIPS MARKET SIZE, BY PROTEOMICS, 2018-2030 (USD MILLION)
TABLE 394. NETHERLANDS BIOCHIPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 395. NETHERLANDS BIOCHIPS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 396. NIGERIA BIOCHIPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 397. NIGERIA BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 398. NIGERIA BIOCHIPS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION

Companies Mentioned

  • Abbott Laboratories
  • ACROBiosystems Inc.
  • Agilent Technologies, Inc.
  • Archer Materials Limited
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Cellix Ltd. by Randox Laboratories Ltd.
  • Diagnostic Biochips, Inc
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies, Inc.
  • Horiba, Ltd.
  • Illumina, Inc.
  • Innovative Biochips, LLC
  • LI-COR, Inc.
  • Luminex Corporation by DiaSorin S.p.A.
  • Merck KGaA
  • Micronit B.V.
  • Nutcracker Therapeutics
  • Opteev
  • PerkinElmer Inc.
  • Phalanx Biotech Group Inc. by WIN Semiconductors Corp.
  • QIAGEN N.V.
  • Sphere Fluidics Limited
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biochip Market Size, Share & Trends Analysis Report by Type (DNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Biochip Market Size, Share & Trends Analysis Report by Type (DNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Biochips - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biochips - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Biochips Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Type, Application, and End-user - Product Image

Biochips Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Type, Application, and End-user

  • Report
  • 117 Pages
  • Global
From
Biochips Market Report by Product Type, Fabrication Technique, Analysis Method, Application, End User, and Region 2024-2032 - Product Image

Biochips Market Report by Product Type, Fabrication Technique, Analysis Method, Application, End User, and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From

About the Biochip Market

Biochips are a type of biotechnology that uses microchips to store and process biological information. They are used in a variety of applications, such as diagnostics, drug discovery, and gene sequencing. Biochips are made up of a variety of components, including transistors, capacitors, and resistors, which are used to store and process biological information. Biochips are used in a variety of industries, including healthcare, agriculture, and environmental monitoring. In healthcare, biochips are used to diagnose diseases, detect genetic mutations, and monitor patient health. In agriculture, biochips are used to monitor crop growth and soil conditions. In environmental monitoring, biochips are used to detect pollutants and monitor water quality. The biochip market is growing rapidly, driven by advances in biotechnology and the increasing demand for personalized medicine. The market is expected to continue to grow in the coming years, as biochips become more widely used in a variety of industries. Some of the major companies in the biochip market include Illumina, Thermo Fisher Scientific, Agilent Technologies, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.